IRIS
FEDERICO, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.097
NA - Nord America 12.622
AS - Asia 10.008
SA - Sud America 1.860
Continente sconosciuto - Info sul continente non disponibili 561
AF - Africa 151
OC - Oceania 30
Totale 50.329
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 15.542
US - Stati Uniti d'America 12.346
SG - Singapore 3.801
IE - Irlanda 2.406
IT - Italia 2.136
CN - Cina 1.970
BR - Brasile 1.529
HK - Hong Kong 1.513
UA - Ucraina 1.286
VN - Vietnam 1.132
GB - Regno Unito 1.068
DE - Germania 631
FI - Finlandia 499
FR - Francia 465
SE - Svezia 385
KR - Corea 339
TR - Turchia 290
GR - Grecia 258
IN - India 232
JP - Giappone 210
BD - Bangladesh 160
AR - Argentina 133
CA - Canada 111
NL - Olanda 92
AT - Austria 87
MX - Messico 84
PL - Polonia 64
ID - Indonesia 57
IQ - Iraq 57
EC - Ecuador 55
ZA - Sudafrica 49
ES - Italia 47
BE - Belgio 37
PK - Pakistan 34
CO - Colombia 32
AU - Australia 28
IR - Iran 26
PY - Paraguay 24
VE - Venezuela 24
UZ - Uzbekistan 22
PE - Perù 20
CL - Cile 18
EG - Egitto 18
MY - Malesia 18
MA - Marocco 17
SA - Arabia Saudita 17
AZ - Azerbaigian 15
CZ - Repubblica Ceca 15
DZ - Algeria 15
DO - Repubblica Dominicana 14
TH - Thailandia 14
HN - Honduras 13
JM - Giamaica 13
TN - Tunisia 13
UY - Uruguay 13
KE - Kenya 12
KZ - Kazakistan 12
BO - Bolivia 11
NP - Nepal 11
CR - Costa Rica 10
LT - Lituania 9
TW - Taiwan 9
CH - Svizzera 8
JO - Giordania 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
AL - Albania 7
ET - Etiopia 7
IL - Israele 7
MK - Macedonia 7
RO - Romania 7
BG - Bulgaria 6
LK - Sri Lanka 6
SN - Senegal 6
AE - Emirati Arabi Uniti 5
GE - Georgia 5
GT - Guatemala 5
NI - Nicaragua 5
NO - Norvegia 5
AM - Armenia 4
CY - Cipro 4
DK - Danimarca 4
KG - Kirghizistan 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
PS - Palestinian Territory 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CI - Costa d'Avorio 3
EU - Europa 3
HR - Croazia 3
HU - Ungheria 3
NG - Nigeria 3
AO - Angola 2
BY - Bielorussia 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 49.743
Salva come PNG Salva come JPEG
Città #
Moscow 5.505
Dublin 2.400
Jacksonville 1.918
Hong Kong 1.485
Singapore 1.480
Santa Clara 1.351
San Jose 1.332
Chandler 1.229
Ashburn 655
Ho Chi Minh City 383
Princeton 378
Beijing 323
Seoul 315
Naples 314
Roxbury 311
Hefei 247
Hanoi 246
Ann Arbor 223
Cambridge 220
New York 212
Boardman 205
Dallas 189
Medford 168
Wilmington 159
Helsinki 149
Council Bluffs 144
Woodbridge 138
The Dalles 130
Bengaluru 118
Los Angeles 117
São Paulo 108
Caserta 99
Rome 99
Houston 93
Munich 93
Des Moines 89
Milan 78
San Mateo 77
Mountain View 66
Da Nang 65
Nanjing 63
Bremen 60
Dong Ket 54
Nuremberg 52
Orem 52
Amsterdam 46
Haiphong 46
Tokyo 44
Vienna 44
Düsseldorf 40
Frankfurt am Main 40
Napoli 40
Belo Horizonte 39
Atlanta 37
Shanghai 37
Rio de Janeiro 36
Chicago 34
Brussels 33
Jinan 33
Kraków 33
Bologna 31
Brasília 31
Porto Alegre 31
Turku 31
Aversa 30
Tianjin 30
Norwalk 29
Paris 29
San Francisco 29
Curitiba 28
Guangzhou 28
Shenyang 28
Potenza 26
Biên Hòa 25
London 24
Memphis 24
Brooklyn 23
Bari 22
Chennai 22
Falkenstein 22
Guayaquil 22
Montreal 22
Phoenix 22
Tashkent 22
Toronto 22
Auburn Hills 21
Johannesburg 21
Mumbai 21
Manchester 20
Mexico City 20
Thái Bình 20
Boydton 19
Campinas 18
Palermo 18
Quito 18
Dhaka 17
Manaus 17
Miami 17
Salvador 17
Warsaw 17
Totale 24.708
Salva come PNG Salva come JPEG
Nome #
Sleisenger e Fordtran. Malattie gastrointestinali ed epatiche. Fisiopatologia, diagnosi e trattamento 376
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity? 226
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 223
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 222
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 211
Integrating Silybin and Sirtuin Related Pathways in Steatosis-Related Liver Diseases 201
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 195
Intrafamilial spread of Helicobacter pylori infection 194
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 186
14-Day, High-Dose Acid Suppression, Non-Bismuth Quadruple Therapies (Hybrid vs. Concomitant) for Helicobacter pylori Infection: A Randomized Trial 183
Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo. 182
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 182
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 181
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 180
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 179
Autoimmune thyroid disease and neuroendocrine gastric tumors: early detection and efficacy of somatostatin analogue treatment. 179
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 178
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life 178
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 175
Chronic inflammation and oxidative stress in human carcinogenesis 175
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 172
Crohn’s disease and skin 172
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 172
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 170
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 170
Antioxidant effects of Silybin, Silybin-phosphatidylcholine complex, and derivatives of Silibinin on in vitro cultured cells damaged by oxidative stress 169
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 168
A case of hepatotoxicity caused by green tea 168
Alteration of haemostasis in non-metastatic gastric cancer 166
A Facebook survey to obtain alcohol-related information by young people and adolescents. An Italian study 165
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 165
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 165
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 163
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 163
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 162
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 162
Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: the interim analysis of the ANSWER study 160
Oral microbiota and salivary levels of oral pathogens in gastro‐intestinal diseases: Current knowledge and exploratory study 160
Polydatin administration improves serum biochemical parameters and oxidative stress markers during chronic alcoholism: a pilot study 159
Activated protein C resistance in nonmetastatic gastric cancer patients. 159
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 158
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 157
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 157
'' Non alcoholic fatty liver disease and eNOS dysfunction in humans '' 156
Aggregazione piastrinica in pazienti con epatite cronica da HCV: studi in vitro. 155
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 155
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 154
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 154
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease 153
AISF position paper on liver disease and pregnancy 153
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study 153
Urotensin-II receptor expression in human colon adenocarcinoma: in vitro and in vivo studies. 152
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 152
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 151
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments 151
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 151
Comparsa di pancreatite acuta ed epatite autoimmune in corso di trattamento con IFN: descrizione di un caso clinico. 149
Tenofovir disoproxil fumarate monotherapy maintains HBV suppression achieved by a "de novo" combination of lamivudine-adefovir: a pilot study 149
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 149
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 149
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 148
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 148
How immunotherapy has changed the continuum of care in hepatocellular carcinoma 148
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 146
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 146
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 145
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 145
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 143
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 143
An Italian survey on dietary habits and changes during the COVID-19 lockdown 143
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 142
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 141
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 141
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 138
Alcohol abuse affects nitric oxide production in patients with chronic liver disease. 138
Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass 138
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens. 138
Light alcohol drinking and the risk of cancer development: a controversial relationship 137
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 137
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis 137
Angiografia perfusionale con mdc di 2a generazione nella valutazione della efficacia necrotica delle terapie ablative percutanee (PAT): studio prospettico vs TC spirale. 136
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 135
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 134
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial 134
Cause di malnutrizione nel paziente neoplastico 134
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 134
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 134
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 133
Endoscopic calcium electroporation for unfit-for-surgery bleeding colorectal cancer: the dawn of a new treatment? 133
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 131
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis 131
Trace elements and chronic liver diseases 131
The Role of Stress in Inflammatory Bowel Diseases 131
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 131
Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam 130
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 130
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 130
Obesità androide postmenopausale: ruolo del DHEA-S, didrotestosterone libero ed SHBG. 130
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 129
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review 129
Totale 15.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.050
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.050
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.138 0 20 27 67 782 32 54 60 88 63 204 741
2022/20234.576 446 120 49 373 453 373 17 304 2.223 44 81 93
2023/20242.083 155 69 78 151 684 169 55 58 32 65 204 363
2024/20256.346 52 78 147 232 1.041 576 723 548 764 1.331 479 375
2025/202626.337 872 1.149 1.401 1.356 2.085 14.562 1.348 1.085 1.058 610 526 285
2026/2027941 232 709 0 0 0 0 0 0 0 0 0 0
Totale 50.329